Global case studies for chronic kidney disease/end-stage kidney disease care.

Framework for establishing integrated kidney care programs in low- and middle-income countries.

Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey.

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes.

Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury.

The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease.

Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.

Promotion of β-catenin/Foxo1 signaling ameliorates renal interstitial fibrosis.

Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.

Functional Comparison of Human and Zebra Fish FKBP52 Confirms the Importance of the Proline-Rich Loop for Regulation of Steroid Hormone Receptor Activity.